INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...
Insulin lispro protamine suspension 75% (rDNA origin), insulin lispro 25% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol. The primary activity of insulin is the regulation of glucose ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a novel, faster-acting insulin lispro injection to improve glycemic response in adults with ...
MUNICH — Investigational technology (BioChaperone, Adocia) that enhances the action of already-approved off-patent insulins could improve glycemic control in patients with type 1 and type 2 diabetes, ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded label for rapid-acting insulin lispro-aabc injection to include administration via ...
Improved Health Outcomes Noted with Dulaglutide Therapy Lilly announced the availability of lower-priced, non-branded versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine and insulin ...
Eli Lilly is continuing to work to lower the out-of-pocket costs for people using insulin. The company announced that it is lowering the list price of Insulin Lispro Injection by an additional 40% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback